Big Gain For Biomotion Sciences
Tue, Feb 25, 2025 at 07:41 PM
Biomotion Sciences (SLXN:NASDAQ) rocketted at $1.23, a gain of 64%. On Tue, Feb 25, 2025, SLXN:NASDAQ hit a New 2-Week Intraday High of $1.53. The stock got featured on our News Catalysts scanner on Tue, Feb 25, 2025 at 10:09 AM in the 'BIOTECH' category. From Wed, Feb 12, 2025, the stock recorded 12.50% Up Days and 22.22% Green Days
The stock spiked on Wed, Jan 29, 2025 at $3.45 with a volume of 330M+.
About Biomotion Sciences (SLXN:NASDAQ)
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
Top 10 Gainers:
- Organovo Holdings, Inc. (ONVO:NASDAQ), 244.17%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 83.05%
- Signature Bank (SBNY:NASDAQ), 78.29%
- Venus Concept Inc. (VERO:NASDAQ), 76.47%
- Biomotion Sciences (SLXN:NASDAQ), 64%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 59.22%
- Femto Technologies Inc. (FMTO:NASDAQ), 50%
- Brera Holdings PLC (BREA:NASDAQ), 48.99%
- mF International Limited (MFI:NASDAQ), 46.04%
- LAVA Therapeutics N.V. (LVTX:NASDAQ), 42.28%